Biological kits
Ended Awarded Last action
- Contract number
- 75N91023F90103
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,258
Award facts
- Contract value 100% obligated
- $24,257.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a BPA call to 10X Genomics, Inc. for biological kits with a ceiling value of $24,257.50 on June 15, 2023. The call is firm fixed price with an ultimate completion date of August 15, 2023. Place of performance is Pleasanton, California. No set-aside applies to this call.
Quick answers
Who was awarded contract 75N91023F90103?
75N91023F90103 was awarded to 10X Genomics, Inc. by National Cancer Institute (National Institutes of Health) on June 15, 2023.
How much is contract 75N91023F90103 worth?
The government has obligated $24,258 on 75N91023F90103.
Is contract 75N91023F90103 an order under another contract?
Yes. 75N91023F90103 is a BPA call under 75N98022A00032, a blanket purchase agreement.
Was contract 75N91023F90103 competed?
The extent of competition for 75N91023F90103 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award